[go: up one dir, main page]

TR201720406A2 - COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY - Google Patents

COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY Download PDF

Info

Publication number
TR201720406A2
TR201720406A2 TR2017/20406A TR201720406A TR201720406A2 TR 201720406 A2 TR201720406 A2 TR 201720406A2 TR 2017/20406 A TR2017/20406 A TR 2017/20406A TR 201720406 A TR201720406 A TR 201720406A TR 201720406 A2 TR201720406 A2 TR 201720406A2
Authority
TR
Turkey
Prior art keywords
multiple sclerosis
skeletal muscle
loaer
combinations containing
sclerosis therapy
Prior art date
Application number
TR2017/20406A
Other languages
Turkish (tr)
Inventor
Palantöken Arzu
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Pehli̇van Akalin Nur
Tuncay Emi̇ne
Peker Merve
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20406A priority Critical patent/TR201720406A2/en
Priority to EP18915063.4A priority patent/EP3723755A4/en
Priority to PCT/TR2018/050800 priority patent/WO2019203752A2/en
Publication of TR201720406A2 publication Critical patent/TR201720406A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, en az bir iskelet kası gevşetici ajan ve en az bir multipl skleroz tedavi edici ajan içeren kombinasyonlarla ilgilidir.The present invention relates to combinations comprising at least one skeletal muscle relaxant agent and at least one multiple sclerosis therapeutic agent.

TR2017/20406A 2017-12-14 2017-12-14 COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY TR201720406A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/20406A TR201720406A2 (en) 2017-12-14 2017-12-14 COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY
EP18915063.4A EP3723755A4 (en) 2017-12-14 2018-12-12 Combinations comprising a skeletal muscle relaxant agent and a multiple sclerosis treating agent
PCT/TR2018/050800 WO2019203752A2 (en) 2017-12-14 2018-12-12 Combinations comprising a skeletal muscle relaxant agent and a multiple sclerosis treating agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20406A TR201720406A2 (en) 2017-12-14 2017-12-14 COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY

Publications (1)

Publication Number Publication Date
TR201720406A2 true TR201720406A2 (en) 2019-07-22

Family

ID=67900478

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20406A TR201720406A2 (en) 2017-12-14 2017-12-14 COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY

Country Status (3)

Country Link
EP (1) EP3723755A4 (en)
TR (1) TR201720406A2 (en)
WO (1) WO2019203752A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117161A1 (en) * 2018-12-07 2020-06-11 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A combination comprising dimethyl fumarate and at least one muscle relaxant agent
WO2020139238A3 (en) * 2018-12-28 2020-07-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations comprising fingolimod and a spasmolytic

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201819202A2 (en) * 2018-12-12 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A COMBINATION CONTAINING ONE MULTIPLE SCLEROSIS AGENT AND AT LEAST ONE MUSCLE RELAXING AGENT
JP7503420B2 (en) * 2020-05-18 2024-06-20 東和薬品株式会社 Pharmaceutical composition containing fingolimod, and its manufacturing method and stabilization method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016073510A1 (en) 2014-11-04 2016-05-12 Adamas Pharmaceuticals, Inc. Methods of administering amantadine compositions
WO2017031276A1 (en) * 2015-08-19 2017-02-23 The Regents Of The University Of California Methods of providing neuroprotective therapy related to administering an estrogen receptor beta ligand

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117161A1 (en) * 2018-12-07 2020-06-11 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A combination comprising dimethyl fumarate and at least one muscle relaxant agent
WO2020139238A3 (en) * 2018-12-28 2020-07-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations comprising fingolimod and a spasmolytic

Also Published As

Publication number Publication date
EP3723755A2 (en) 2020-10-21
WO2019203752A2 (en) 2019-10-24
WO2019203752A3 (en) 2020-01-16
EP3723755A4 (en) 2021-09-15

Similar Documents

Publication Publication Date Title
IL280536A (en) Muscle oriented clasps and their uses
PH12020550622A1 (en) Kras g12c inhibitors
MX2023010042A (en) Modulatory polynucleotides.
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
MX2019003938A (en) Spirocyclic compounds.
EA201991997A1 (en) COMBINED THERAPY
ZA201807518B (en) Benzenesulfonamide compounds and their use as therapeutic agents
IL267143A (en) Benzenesulfonamide compounds and their use as therapeutic agents
TR201720406A2 (en) COMBINATIONS CONTAINING A SKELETAL MUSCLE LOAER AND A MULTIPLE SCLEROSIS THERAPY
IL278949A (en) Benzenesulfonamide compounds and their use as therapeutic agents
BR112018000217A2 (en) improved nanoparticle distribution systems
MX2019001634A (en) AMIDAS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THESE AND METHODS TO USE THEM.
EA201990567A1 (en) COMBINED THERAPY WITH GLUTAMINASE INHIBITORS
PH12017502028A1 (en) Vortioxetine pyroglutamate
MX379622B (en) Spirocyclic compounds
MX2020005483A (en) Ildr2 antagonists and combinations thereof.
WO2016130581A8 (en) Combination cancer therapy
AU201810263S (en) Soap Bar
MX2017012610A (en) Compositions and methods for inhibiting expression of the lect2 gene.
MX2019002901A (en) Treatment of multiple sclerosis with chs-131.
GB2564990A (en) Topical compositions for neuropathic pain
TR201721824A2 (en) A MODIFIED EMISSION COMBINATION CONTAINING LINAGLIPTIN AND METFORMIN
CY1122708T1 (en) OXA-DIAZASPIRE COMPOUNDS WITH ACTION AGAINST PAIN
PH12018500579A1 (en) Fungal keratitis prophylactic or therapeutic agent
HUE057090T2 (en) Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer